AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
281.12
+4.65 (1.68%)
At close: Oct 12, 2026, 4:00 PM EDT
281.00
-0.12 (-0.04%)
After-hours: Oct 12, 2026, 7:59 PM EDT
AbbVie Market Cap
AbbVie has a market cap or net worth of $496.77 billion as of October 12, 2026. It is the 28th most valuable company in the world and the 21st biggest in the United States. Its market cap has increased by 22.00% in one year.
Market Cap
496.77B
Enterprise Value
561.09B
1-Year Change
22.00%
Global Rank
Country Rank
#21 United States
Category
ChartMarket Cap Chart
Since January 2, 2013, AbbVie's market cap has increased from $55.49B to $496.77B, an increase of 795.25%. That is a compound annual growth rate of 17.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 496.77B | 23.02% |
| Dec 31, 2025 | 403.83B | 28.60% |
| Dec 31, 2024 | 314.02B | 14.77% |
| Dec 29, 2023 | 273.61B | -4.27% |
| Dec 30, 2022 | 285.80B | 19.40% |
| Dec 31, 2021 | 239.37B | 26.54% |
| Dec 31, 2020 | 189.17B | 44.48% |
| Dec 31, 2019 | 130.93B | -5.58% |
| Dec 31, 2018 | 138.67B | -10.18% |
| Dec 29, 2017 | 154.39B | 51.71% |
| Dec 30, 2016 | 101.76B | 5.08% |
| Dec 31, 2015 | 96.84B | -7.12% |
| Dec 31, 2014 | 104.26B | 24.10% |
| Dec 31, 2013 | 84.01B | 51.40% |
| Jan 2, 2013 | 55.49B | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 1.05T |
| Johnson & Johnson | 630.04B |
| Merck & Co. | 359.22B |
| Novartis AG | 272.48B |
| AstraZeneca | 246.25B |
| Amgen | 224.29B |
| Gilead Sciences | 187.44B |
| Novo Nordisk | 169.11B |